Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
CPRX on Nasdaq
Molly Harper - trading volume in the past year for Catalyst Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
125K |
$142K |
$1.13 |
Feb 15, 2024 |
Direct |
Common Stock |
|
| Common Stock, par value $0.001 per share |
0 |
$0 |
$16.30 |
Jun 3, 2024 |
Direct |
|
|
| Options to purchase common stock |
131K |
|
|
Dec 15, 2023 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.